22 May 2020
Visiongain has launched a new report Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis.
The automation in biopharma market is projected to grow at a CAGR of 4.3% in the first half of the forecast period. In 2019, the automation market in biopharmaceutical industry in clinical stage accounted for 62.1% of the automation in biopharmaceutical market. Visiongain estimated that ERP automation in biopharma will be the driver for market growth in the first half of the forecast period.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Automation in biopharma market forecasts from 2020-2030
• This report assesses the application of automation in the biopharma market and gives revenue to 2030
• Provides qualitative analysis and forecast of the submarket by technology for the period 2020-2030:
• Automation Technology
• Digitization Technology
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing
• Profiles leading companies that will be important in the development of the automation in biopharma market. For each company, developments and outlooks are discussed and companies covered in this chapter include:
• Thermo Fisher Scientific
• Zenith (Cognizant)
• RheoSense, Inc.
• Provides qualitative analysis of trends and developments that will affect the automation in biopharma market, from the perspective of biopharmaceutical companies, during the period 2020 to 2030.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032.
02 August 2022
The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR of 25.52% during the forecast period 2022-2032.
27 July 2022
The global biosimilar monoclonal antibodies market was valued at US$4,087 million in 2021 and is projected to grow at a CAGR of 23.5% during the forecast period 2022-2032.
25 July 2022
The global drug discovery services market is anticipated to be valued at US$14.17 billion in 2022 and is projected to grow at a CAGR of 15.17% during the forecast period 2022-2032.